A proof of concept, phase II study of Ropivacaine Transdermal Patch for Neuropathic Pain.
Phase of Trial: Phase II
Latest Information Update: 19 May 2017
At a glance
- Drugs Ropivacaine (Primary)
- Indications Neuropathic pain; Pain
- Focus Therapeutic Use
- 19 May 2017 New trial record
- 09 May 2017 According to a tesa Labtec media release, company is endeavoring to find a product partner in order to continue the development of this phase.